GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » INIFY Laboratories AB (OSL:INIFY) » Definitions » FCF Margin %

INIFY Laboratories AB (OSL:INIFY) FCF Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is INIFY Laboratories AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. INIFY Laboratories AB's Free Cash Flow for the three months ended in Sep. 2024 was kr0.00 Mil. INIFY Laboratories AB's Revenue for the three months ended in Sep. 2024 was kr2.92 Mil. Therefore, INIFY Laboratories AB's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, INIFY Laboratories AB's current FCF Yield % is 0.00%.

The historical rank and industry rank for INIFY Laboratories AB's FCF Margin % or its related term are showing as below:


OSL:INIFY's FCF Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -4.99
* Ranked among companies with meaningful FCF Margin % only.


INIFY Laboratories AB FCF Margin % Historical Data

The historical data trend for INIFY Laboratories AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INIFY Laboratories AB FCF Margin % Chart

INIFY Laboratories AB Annual Data
Trend Dec21 Dec22 Dec23
FCF Margin %
- - -

INIFY Laboratories AB Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of INIFY Laboratories AB's FCF Margin %

For the Diagnostics & Research subindustry, INIFY Laboratories AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


INIFY Laboratories AB's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, INIFY Laboratories AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where INIFY Laboratories AB's FCF Margin % falls into.



INIFY Laboratories AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

INIFY Laboratories AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0/1.227
=0.00 %

INIFY Laboratories AB's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0/2.917
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


INIFY Laboratories AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of INIFY Laboratories AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


INIFY Laboratories AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeles vag 3, Solna, SWE, 171 65
INIFY Laboratories AB provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized, and AI-supported workflow to optimize quality and response times, initially within the prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer's organization.

INIFY Laboratories AB Headlines

No Headlines